 |
Passage Bio
Last updated: September 30, 2025
Founder James Wilson
USA | Funding: $379.5M (+)
Website: http://www.passagebio.com
Passage Bio is a fully integrated gene therapy company with a mission to develop a portfolio of five life-transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases.
Website: http://www.passagebio.com
Passage Bio is a fully integrated gene therapy company with a mission to develop a portfolio of five life-transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases.
